A new phase II trial finds that PET scans obtained before and midway through treatment for p16-positive oropharynx cancer (OPC) can help determine whether a patient can receive a lower dose of radiation therapy in the second half of their treatment course without compromising cancer control.
A new study from the University of Michigan Health Rogel Cancer Center finds circulating tumor DNA, or ctDNA, levels can predict as early as two weeks after starting treatment which patients are likely to have good outcomes.
Celina Pitt was diagnosed with adenoid cystic carcinoma -- a kind of head and neck cancer -- and had a lot of difficulty coping with the side effects from it. She lost much of her sense of smell and taste and it was hard to relax or feel comfortable. And then her husband, Ed, suggested they try dancing.
A team of scientists affiliated with the led by the University of Michigan Rogel Cancer Center and School of Dentistry, identified a mechanism by which head and neck cancer cells subvert adjacent normal tissue, allowing small clusters of cancer cells to burrow beneath the healthy tissue.
National Cancer Institute-designated cancer centers and leading cancer organizations issued a joint statement urging the nation’s physicians, parents and young adults to get back on track with the human papillomavirus, or HPV, vaccination.
A team of researchers from the Rogel Cancer Center have received a $2.9 million grant from the National Cancer Institute to look at how HPV behaves in patients with head and neck cancer and how that could help identify who might benefit from less-aggressive treatment.
This 'Cancer Moonshot' research grant has been awarded to the University of Michigan's Dental School. Dr. Yu Leo Lei, a Rogel Cancer Center member, will lead researchers from U-M, other universities on new cancer prevention therapies.
MENU
